Nordic Walk on Balance and Functional Strength in Children With Down Syndrome

Sponsor
Riphah International University
Study ID
NCT06943508
Status
Recruiting
Apply to this trial

Conditions

  • Down Syndrome

Eligibility Criteria

Sex
ALL
Age
8 Years - 13 Years
Healthy Volunteers
Not accepted

Interventions

  • Conventional Therapy — OTHER
    Conventional Therapy group: Group A will be control group which will recieve conventional physical therapy program like curl up, lateral step up and sit to stand for 6 weeks( 5 sessions per week)
  • Nordic Walk — OTHER
    Nordic Walk group: Group B will recieve Nordic walking for 6 weeks ( 5 sessions per week)

Study Details

Down syndrome (DS) is one of the more commonly occurring genetic disorders, where mental retardation is combined with nutritional diseases. It is caused by having a third copy of chromosome 21, and there exist 3 forms; Simple Trisomy 21, Translocation Trisomy and Mosaic Trisomy. It is coupled with mental retardation, congenital heart defects, gastrointestinal anomalies .Nordic walking exerts beneficial effects on resting heart rate, blood pressure, exercise capacity, maximal oxygen consumption, and quality of life in patients with various diseases and can thus be recommended to a wide range of people as primary and secondary prevention. This study will aim to examine the effects of Nordic walk on balance and functional strength in children with Down syndrome. A Randomized Controlled Trial will be conducted through convenient sampling 32 subjects will randomly be allocated into two groups. Group A will include 16 children and will receive conventional exercise program. Group B will include 16 children and will receive Nordic walking program. Each session will be 30 minutes, 5 sessions per week. The total duration of the study will be 6 weeks. Pediatric berg balance scale and modified time up and go test, and functional strength test will be used as outcome measure Data will be analyzed on SPSS version 29.0, normality of the data will be checked and tests will be applied according to the normality of the data either it will be parametric test or non-parametric based on the normality.

Key Dates

First listed
Apr 24, 2025
Start date
Apr 15, 2025
Status verified
Apr 2025
Primary completion
Apr 15, 2025
Completion
May 26, 2025

Study Design

Enrollment
32 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER

Arms

  • Active Comparator: Group A
    Control: Conventional therapy program for 30 min , 5 days per week during 6 week period
  • Experimental: Group B
    Experimental: Nordic Walk for 30 min, 5 days per week during 6 week period

Primary Outcome Measure

Pediatric berg balance scale [ Time Frame: Baseline, 6th week ]

Central Contacts

Related Studies